Slagle Financial’s AbbVie ABBV Stock Holding History

Slagle Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Hold	5,092	–	–	0.38%	64
2026 Q1	$1.11M	Buy	5,092 +188	+4%	+$41.7K	0.37%	67
2025 Q4	$1.12M	Buy	4,904 +47	+1%	+$10.7K	0.39%	69
2025 Q3	$1.12M	Buy	4,857 +18	+0.4%	+$3.67K	0.41%	66
2025 Q2	$898K	Buy	4,839 +27	+0.6%	+$5.02K	0.36%	69
2025 Q1	$1.01M	Sell	4,812 -276	-5%	-$53.7K	0.45%	59
2024 Q4	$904K	Sell	5,088 -316	-6%	-$58.1K	0.41%	61
2024 Q3	$1.07M	Sell	5,404 -50	-0.9%	-$9.33K	0.47%	61
2024 Q2	$936K	Sell	5,454 -204	-4%	-$33.8K	0.48%	62
2024 Q1	$1.03M	Sell	5,658 -6,890	-55%	-$1.19M	0.56%	63
2023 Q4	$974K	Buy	12,548 +5,955	+90%	+$868K	0.56%	59
2023 Q3	$983K	Sell	6,593 -233	-3%	-$34.2K	0.6%	59
2023 Q2	$920K	Buy	+6,826	New	+$1M	0.57%	60

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Slagle Financial's ABBV Position: Q2 2026 in Review

Slagle Financial held its AbbVie (ABBV) position steady in Q2 2026 at 5,092 shares worth $1.28M. The position accounts for 0.38% of the portfolio, ranked #64.

Slagle Financial first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Slagle Financial held 5,092 shares of AbbVie worth $1.28M as of Q2 2026.
Slagle Financial left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.38% of Slagle Financial's portfolio in Q2 2026, its #64 holding.
Slagle Financial first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Slagle Financial's 13F filing for Q2 2026, filed 29 Jul 2026.